Although our study followed a clinical evaluation, rather than a molecular analysis, it was previously determined that patients with a history of HF had elevated cardiac NT-proBNP and troponin I indicators and were more likely to suffer myocardial infarction [22]. This evidence concerns the gene NPPB and myocardial infarction.